Biochemical and Metabolic Engineering of Saccharomyces cerevisiae for the Biosynthesis of Olivetolic Acid, a Key Cannabinoid Precursor
Biotechnology Journal · 2025
DOI: 10.1002/biot.70042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2025. Verfasst von Kilan J Schäfer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biochemical and Chemical Engineering, TU Dortmund University, Dortmund, NRW, Germany. Hauptthemen laut MEDLINE: Saccharomyces cerevisiae, Metabolic Engineering, Cannabinoids. Die Arbeit nennt 75 Literaturangaben. Gefördert von: European Regional Development Fund, Bundesministerium für Bildung und Forschung, State of North Rhine Westfalia (NRW).
Abstract (Originalsprache)
Cannabinoids comprise a large class of bioactive compounds found primarily in the plant species Cannabis sativa and are of interest due to their pharmacological and therapeutic potential. The aromatic polyketide, olivetolic acid (OA), is a major precursor in the cannabinoid biosynthesis pathway and is derived from hexanoyl‐CoA and malonyl‐CoA by the action of olivetol synthase (OLS) and olivetolic acid cyclase (OAC). To date, most microbial cannabinoid production systems rely on the external supplementation of hexanoic acid together with the overexpression of acyl‐activating enzyme 1 from C. sativa ( Cs AAE1 ) to provide hexanoyl‐CoA. Here, we implement a heterologous OA biosynthesis pathway into the yeast Saccharomyces cerevisiae and describe various biochemical and metabolic engineering strategies to overcome the need for external hexanoic acid supplementation. We ensured a sufficient endogenous supply of hexanoyl‐CoA and further optimized OA production by enhancing precursor supply. Moreover, we present a mutant phenylacetate‐CoA ligase derived from Penicillium chrysogenum ( Pc PCL‐K ) which displayed superior hexanoyl‐CoA ligase activity to Cs AAE1 . Together, these strategies enabled the production of 180 mg/L OA using shake flask cultures. Our results provide details of key metabolic engineering steps required for the biosynthetic production of cannabinoids and their precursors in S. cerevisiae .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Biochemical and Chemical Engineering, TU Dortmund University, Dortmund, NRW, Germany.
- Institute of Molecular Biosciences, Faculty of Biological Sciences, Goethe University Frankfurt, Frankfurt am Main, Hessen, Germany.
ORCID-Profile: Kilan J Schäfer, Oliver Kayser
Förderung
- European Regional Development Fund
- Bundesministerium für Bildung und Forschung
- State of North Rhine Westfalia (NRW)
Zitieren
APA
Schäfer, K. J., Chalwatzis, L., Feka, A. M., Aras, M., Boles, E., & Kayser, O. (2025). Biochemical and Metabolic Engineering of Saccharomyces cerevisiae for the Biosynthesis of Olivetolic Acid, a Key Cannabinoid Precursor. Biotechnology Journal. https://doi.org/10.1002/biot.70042
Vancouver
Schäfer KJ, Chalwatzis L, Feka AM, Aras M, Boles E, Kayser O. Biochemical and Metabolic Engineering of Saccharomyces cerevisiae for the Biosynthesis of Olivetolic Acid, a Key Cannabinoid Precursor. Biotechnology Journal. 2025. doi:10.1002/biot.70042
BibTeX
@article{Schfer2025,
author = {Schäfer, Kilan J and Chalwatzis, Lukas and Feka, Athanasia M and Aras, Marco and Boles, Eckhard and Kayser, Oliver},
title = {Biochemical and Metabolic Engineering of Saccharomyces cerevisiae for the Biosynthesis of Olivetolic Acid, a Key Cannabinoid Precursor},
journal = {Biotechnology Journal},
year = {2025},
doi = {10.1002/biot.70042}
}
EUVIMED